NICE guidelines on urinary incontinence in women [8]

Age and Ageing

Volumn 36, Issue 3, 2007, Pages 349-350

  Woodford, Henry ^a   George, James ^a  

^a CUMBERLAND INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT;

BLURRED VISION; BRAIN INFARCTION; COGNITIVE DEFECT; COMORBIDITY; DELIRIUM; DEMENTIA; FEMALE; HUMAN; IMMOBILIZATION; LETTER; MINI MENTAL STATE EXAMINATION; NURSING HOME; ORTHOSTATIC HYPOTENSION; POLYPHARMACY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; SCREENING TEST; URINE INCONTINENCE; XEROSTOMIA; AGED; ELDERLY CARE; FRAIL ELDERLY; GOVERNMENT; UNITED KINGDOM;

AGED; FEMALE; FRAIL ELDERLY; GOVERNMENT AGENCIES; GREAT BRITAIN; HEALTH SERVICES FOR THE AGED; HUMANS; PRACTICE GUIDELINES; URINARY INCONTINENCE;

EID: 34250625266     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afm043     Document Type: Letter

References (15)

1. NICE. Urinary Incontinence: The Management of Urinary Incontinence in Women. 2006; www.nice.org.uk/CG040.
2. Chiang L, Ouslander J, Schnelle J et al. Dually incontinent nursing home residents: Clinical characteristics and treatment differences. J Am Geriatr Soc 2000; 48: 673-6.
3. Skelly J, Flint AJ. Urinary incontinence associated with dementia. J Am Geriatr Soc 1995; 43: 286-94.
4. Fantl JA, Wyman JF, McClish DK et al. Efficacy of bladder training in older women with urinary incontinence. JAMA 1991; 265: 609-13.
5. Burgio KL, Locher JL, Goode PS et al. Behavioral vs drug treatment for urge urinary incontinence in older women: A randomized controlled trial. JAMA 1998; 280: 1995-2000.
6. Malone-Lee JG, Walsh JB, Maugourd M et al. Tolterodine: A safe and effective treatment for older patients with overactive bladder. J Am Geriatr Soc 2001; 49: 700-5.
7. Resnick NM, Yalla SV, Laurino E. The pathophysiology of urinary incontinence among institutionalized elderly persons. N Engl J Med 1989; 320: 1-7.
8. Zinner NR, Mattiasson A, Stanton SL. Efficacy, safety and tolerability of extended-release once-daily tolterodine treatment for overactive bladder in older versus younger patients. J Am Geriatr Soc 2002; 50: 799-807.
9. Donnellan CA, Fook L, McDonald P et al. Oxybutynin and cognitive dysfunction. Br Med J 1997; 315: 1363-4.
10. Katz IR, Sands LP, Bilker W et al. Identification of medications that cause cognitive impairment in older people: The case of oxybutynin chloride. J Am Geriatr Soc 1998; 46: 8-13.
11. Edwards KR, O'Connor JT. Risk of delirium with concomitant use of tolterodine and acetylcholinesterase inhibitors. J Am Geriatr Soc 2002; 50: 1165-6.
12. Tsao JW, Heilman KM. Transient memory impairment and hallucinations associated with tolterodine Use. N Engl J Med 2003; 349: 2274-75.
13. Perry EK, Kilford L, Lees AJ et al. Increased Alzheimer pathology in Parkinson's disease related to antimuscarinic drugs. Ann Neurol 2003; 54: 235-8.
14. Williams SG, Staudenmeier J. Hallucinations with tolterodine. Psychiatr Serv 2004; 55: 1318-9.
15. The Royal College of Physicians and British Geriatrics Society. The prevention, diagnosis and management of delirium in older people. June 2006; Available at www.bgs.org.uk.